Predictive Oncology Inc. Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2024 | 1 | $1.34 | $1.34 | $1.34 |
| Q2 2024 | 1 | -$0.32 | -$0.32 | -$0.32 |
| Q3 2024 | 1 | -$0.26 | -$0.26 | -$0.26 |
| Q1 2025 | 1 | -$0.10 | -$0.10 | -$0.10 |
| Q2 2025 | 1 | -$0.09 | -$0.09 | -$0.09 |
| Q3 2025 | 1 | -$0.10 | -$0.10 | -$0.10 |
| Q4 2025 | 1 | $0.05 | $0.05 | $0.05 |
Predictive Oncology Inc. Earnings Date And Information
Predictive Oncology Inc. last posted its earnings results on Tuesday, March 21st, 2023. The company reported $-2 earnings per share for the quarter, missing analysts' consensus estimates of $-0.06 by $1.94. The company had revenue of 278,722 for the quarter and had revenue of 1.78 M for the year. Predictive Oncology Inc. has generated $-3 earnings per share over the last year ($-3.48 diluted earnings per share) and currently has a price-to-earnings ratio of -0.25. Predictive Oncology Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Monday, November 11th, 2024 based on prior year's report dates.
Predictive Oncology Inc. Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 08/13/2024 | Q2 2024 | -$0.68 | $278,722 | $278,722 | ||
| 05/14/2024 | Q1 2024 | -$1.04 | $419,646 | |||
| 03/28/2024 | Q4 2023 | -$0.86 | $335,032 | |||
| 11/13/2023 | Q3 2023 | -$0.78 | $715,056 | |||
| 08/10/2023 | Q2 2023 | -$0.98 | $490,110 | |||
| 05/15/2023 | Q1 2023 | -$1.07 | $239,895 | |||
| 03/21/2023 | Q4 2022 | -$0.06 | -$5.65 | -5.59 | $363,473 | |
| 11/10/2022 | Q3 2022 | -$0.20 | -$1.02 | -0.82 | $4.00 M | $455,827 |
| 08/11/2022 | Q2 2022 | -$0.60 | -$5.08 | -4.48 | $2.00 M | $371,591 |
| 05/12/2022 | Q1 2022 | -$0.80 | -$1.01 | -0.21 | $314,568 | |
| 03/31/2022 | Q4 2021 | -$0.23 | -$0.12 | 0.11 | $476,493 | |
| 11/10/2021 | Q3 2021 | -$1.00 | -$1.66 | -0.66 | $600,000 | $313,663 |
| 08/11/2021 | Q2 2021 | -$1.40 | -$1.00 | 0.4 | $600,000 | $350,207 |
| 05/12/2021 | Q1 2021 | -$0.09 | -$2.20 | -2.11 | $280,317 | |
| 03/15/2021 | Q4 2020 | -$0.18 | -$0.76 | -0.58 | $293,788 | |
| 11/16/2020 | Q3 2020 | -$8.46 | $480,757 | |||
| 08/13/2020 | Q2 2020 | -$7.27 | $182,784 | |||
| 06/08/2020 | Q1 2020 | -$18.61 | $294,943 | |||
| 04/01/2020 | Q4 2019 | -$2.79 | $347,477 | |||
| 11/15/2019 | Q3 2019 | -$25.48 | $522,696 |
Predictive Oncology Inc. Earnings: Frequently Asked Questions
-
When is Predictive Oncology Inc.'s earnings date?
Predictive Oncology Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Monday, November 11th, 2024 based off last year's report dates.
-
How can I listen to Predictive Oncology Inc.'s earnings conference call?
The conference call for Predictive Oncology Inc.'s latest earnings report can be listened to online.
-
How can I read Predictive Oncology Inc.'s conference call transcript?
The conference call transcript for Predictive Oncology Inc.'s latest earnings report can be read online.
-
How much revenue does Predictive Oncology Inc. generate each year?
Predictive Oncology Inc. (:POAI) has a recorded annual revenue of $1.78 M.
-
How much profit does Predictive Oncology Inc. generate each year?
Predictive Oncology Inc. (:POAI) has a recorded net income of $1.78 M. Predictive Oncology Inc. has generated $-3.48 earnings per share over the last four quarters.
-
What is Predictive Oncology Inc.'s price-to-earnings ratio?
Predictive Oncology Inc. (:POAI) has a price-to-earnings ratio of -0.25 and price/earnings-to-growth ratio is -0.03.
